Target intelligence / Profile preview

Immunoglobulin lambda variable 3-17 (pseudogene) (IGLV3-17)

Target
IGLV3-17
Molecular classification
Other (Immunoglobulin pseudogene)
01

Overview

Immunoglobulin lambda variable 3-17 (IGLV3-17) is a **pseudogene** member of the immunoglobulin lambda variable (IGLV) gene cluster in humans[1][3][4][8]. Unlike functional immunoglobulin variable genes, **IGLV3-17 does not encode a functional protein** and is not involved in forming the antigen-binding domains of immunoglobulins (antibodies)[1][3]. The IGLV gene family consists of both functional genes and pseudogenes; IGLV3-17 is classified as a pseudogene, meaning it has lost its protein-coding potential through mutations[5]. IGLV3-17 is **not considered a therapeutic target** (such as a receptor, enzyme, transporter, etc.), nor is it known to have a disease association, biomarker role, or interaction with drugs[1][3][4][8]. It is referenced in gene nomenclature resources as part of the broader immunoglobulin lambda variable gene cluster, but specific roles or mechanisms of action do not apply to this locus due to its pseudogene status[5].

Other names
IGLV317V2-12P

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-17 (pseudogene) (IGLV3-17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-17 (pseudogene) (IGLV3-17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call